Oppenheimer & Co’s Rosetta Genomics ROSG Stock Holding History
Bought
Maintained
Sold
Other funds holding ROSG
HCM
Oppenheimer & Co's ROSG Position: Q1 2014 in Review
Oppenheimer & Co sold out of Rosetta Genomics (ROSG) in Q1 2014, closing a stake of 3,750 shares — an estimated $131K sold.
Oppenheimer & Co first reported a position in ROSG in Q2 2013 and held it in 3 quarters. The position peaked at $153K in Q2 2013. 18 funds tracked by Wall St. Rank hold ROSG as of Q1 2014.
- Oppenheimer & Co reported no remaining Rosetta Genomics position as of Q1 2014 after selling out during the quarter.
- Oppenheimer & Co sold 3,750 Rosetta Genomics shares in Q1 2014, an estimated $131K.
- Oppenheimer & Co first reported a position in Rosetta Genomics in Q2 2013 and held it in 3 quarters.
- Oppenheimer & Co's Rosetta Genomics position peaked at $153K in Q2 2013.
- 18 funds tracked by Wall St. Rank held Rosetta Genomics as of Q1 2014.
Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.